Industry Overview

North American medical robotics market was valued at $9.74 billion in 2025 and is projected to reach $38.71 billion by 2035, growing at a CAGR of 14.9% during the forecast period (2026–2035). The North American medical robotics market is experiencing significant growth, driven by increasing adoption of minimally invasive procedures, technological advancements, and rising demand for improved patient outcomes. Hospitals and surgical centers are investing in robotic systems to enhance precision, reduce recovery times, and optimize operational efficiency. The growing prevalence of chronic and neurological disorders, combined with aging populations, is fueling demand for rehabilitative and therapeutic robotics. Continuous product innovation, coupled with strong regulatory support and reimbursement frameworks, is encouraging broader deployment across healthcare facilities. Strategic partnerships and expansions by leading companies are further accelerating market momentum. Overall, the market is poised to expand steadily during the forecast period.

Market Dynamics

Expansion of Surgical Robotics

Surgical robotic systems are gaining traction across hospitals and specialty centers in the region, supported by increasing preference for minimally invasive and precision-guided procedures. Companies such as Intuitive Surgical, Medtronic, and Stryker are continuously enhancing their platforms with improved imaging, AI-assisted navigation, and instrument versatility. Adoption is further driven by rising surgeon training programs, improved patient outcomes, and hospital efficiency gains. Integration with digital health systems is enabling workflow optimization and real-time analytics. The market is expected to grow steadily as new clinical applications and system upgrades are introduced.

Growth of Rehabilitative and Therapeutic Robotics

Rehabilitative robotics is emerging as a fast-growing segment, fueled by aging populations, higher incidence of neurological disorders, and increasing demand for home-based therapies. Key players such as Hocoma, Tyromotion, and Ottobock are expanding clinical trials, payer collaborations, and tele-rehabilitation initiatives. Portable exoskeletons and AI-driven therapy platforms are becoming more accessible, enabling personalized recovery programs. Sensor-based analytics and remote monitoring improve adherence and therapy outcomes. Regulatory support and funding for devices demonstrating functional improvements are key accelerators. This segment is expected to see robust growth across outpatient, home, and rehabilitation centers during the forecast period.

Market Segmentation

• Based on the product, the market is segmented into surgical robotic systems, rehabilitative robotic systems, noninvasive radiosurgery robots, hospital & pharmacy robotic systems, and others.

Surgical Robot Systems Segment to Lead the Market with the Largest Share

Surgical robotics is expanding due to the rising need for minimally invasive procedures, enhanced precision, and faster patient recovery. The market players such as Intuitive Surgical, Medtronic, and Stryker continue to innovate with AI-driven navigation, modular instruments, and hybrid platforms. Hospitals are increasingly integrating these systems to optimize workflow and reduce procedural errors. Recent trends include multi-specialty applications, robotic-assisted orthopedic surgery, and enhanced imaging integration. Investment in training and service infrastructure supports adoption across the region. Market growth is expected to remain strong throughout the forecast period.

Rehabilitative Robotics Systems: A Key Segment in Market Growth

Rehabilitative robotics is growing rapidly, driven by demographic aging, higher neurological disorder prevalence, and demand for outcomes-focused, home-based therapies. Convergence of sensor analytics, personalized progression, and remote monitoring enhances patient adherence and recovery. Funding initiatives and regulatory approvals for devices showing functional improvements accelerate adoption. Hospitals, rehabilitation centers, and home-care providers are increasingly incorporating these solutions. The segment is projected to expand significantly during the forecast period.

Regional Outlook

The North American medical robotics market is further divided by countries, including the US and Canada.

The US Dominates the Market with a Major Share

The US is expected to dominate the North American medical robotics market due to advanced healthcare infrastructure, high investment in R&D, and early adoption of innovative technologies. Major players such as Intuitive Surgical, Medtronic, and Stryker have a strong presence and extensive installed bases in the country. Favorable reimbursement policies, large hospital networks, and a growing focus on minimally invasive and precision-guided procedures further fuel adoption. Continuous innovation in surgical, rehabilitative, and therapeutic robotics strengthens the country’s leadership. The US market is expected to grow significantly during the forecast period, maintaining its dominant position in the region.

Market Players Outlook

The major companies operating in the North American medical robotics market include Intuitive Surgical Operations, Inc., Stryker Corp., Medtronic Inc., Hocoma AG, CMR Surgical Ltd., Elekta AB, Zimmer Biomet Holdings, Inc., Renishaw Plc, and Omnicell, Inc., among others. Market players are leveraging partnerships, collaborations, mergers, and acquisition strategies for business expansion and innovative product development to maintain their market positioning.

Recent Developments

• In October 2025, Johnson & Johnson MedTech announced advancements in developing the company’s robotics systems with physical AI technologies that create simulated environments to accelerate future product innovation, optimize clinical workflows, and improve training for clinical teams.

• In October 2025, Monteris Medical announced a strategic partnership to evolve surgical precision with the use of advanced robotics for brain ablation surgery and expand the capabilities of MRI-guided neurosurgical procedures.

• In March 2024, Intuitive announced that the US Food and Drug Administration (FDA) provided 510(k) clearance for da Vinci 5, the company’s next-generation multiport robotic system. Da Vinci 5 builds on Intuitive’s da Vinci Xi’s highly functional design, which surgeons and care teams around the world have used in more than 7 million procedures to date. The system includes more than 150 enhancements, including improved accuracy and precision, next-generation 3D display, image processing, and more.

The Report Covers

• Market value data analysis of 2025 and forecast to 2035.
• Annualized market revenues ($ million) for each market segment.
• Country-wise analysis of major geographical regions.
• Key companies operating in the North American medical robotics market. Based on the availability of data, information related to new products and relevant news is also available in the report.
• Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
• Analysis of market-entry and market expansion strategies.
• Competitive strategies by identifying ‘who-stands-where’ in the market.